This study also showed a trend for improved OS and PFS when radiation was combined with immunochemotherapy in patients with oligometastasis (HR: 0.34 and 0.36, respectively).
← all excerpts
Role of radiotherapy in extensive-stage small cell lung cancer after durvalumab-based immunochemotherapy: A retrospective study.
1
—
—